FMT Capsules for rCDI
Recruiting
Phase 3
Interventional Study
Clostridioides Difficile Infection Recurrence
FMT
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 76 (estimated)
- Sponsor
- Helsinki University Central Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Double blind RCT study of tretment of recurrent Clostridioides difficile infection by FMT capsules.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* At least twice recurrent CDI\*
* Patient has had CDI-related diarrhea during infections (3 or more Bristol Stool Form Scale type 6-7 stools)
* Other causes of diarrhea have been excluded based on clinical data
* Age over 18 years
* Remission of symptoms during antibiotic cours…
Contacts